Skip to main content

Table 3 Pulse wave analysis in both cohorts

From: Increased augmentation index in patients with Ehlers-Danlos syndrome

  EDS cohort (n = 61) Healthy control cohort (n = 61) p-value
Aortic AIx (AP/PP) @HR 75, % 22.8 ± 10.1 14.8 ± 14.0 < 0.001
P1 height, mmHg 20 (16/23) 20 (17/24) 0.438
Peripheral T1, ms 113 (104/122) 109 (104/119) 0.288
Peripheral T2, ms 200 (191/212) 209 (202/221) 0.002
Peripheral AIx, % 80.4 ± 18.2 72.5 ± 17.2 0.017
End systolic pressure, mmHg 102 (92/109) 97 (91/105) 0.103
Ejection duration, ms 296 (276/309) 302 (288/316) 0.025
Heart rate, min−1 76 (67/83) 67 (63/72) < 0.001
Mean pressure systolic, mmHg 99 (91/107) 96 (90/102) 0.142
Mean pressure diastolic, mmHg 89 (82/96) 85 (79/91) 0.069
  1. AIx Augmentation index; EDS Ehlers-Danlos Syndrome; HR heart rate